The current valuation score of X T L Biopharmaceuticals Ltd is 9.97, ranking 1 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -3.70, which is -100.00% below the recent high of 0.00 and -1202.87% above the recent low of -48.26.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.